Tae Hyun Kim
Seoul National University · Medicine
About the Lab
Professor Tae Hyun Kim's research lab focuses on translational biomedical research with a strong emphasis on cancer therapeutics and metabolic liver diseases. The lab investigates the biological effects of nanomaterials, particularly silver nanoparticles, in relation to size-dependent cytotoxicity and cellular stress responses. It also explores radiation therapy optimization, including proton beam therapy and 3D conformal radiation, for hepatocellular carcinoma and other thoracic and abdominal cancers. Additionally, the lab examines molecular mechanisms regulating hepatic glucose metabolism, particularly the role of nuclear receptors like LXRα and transcription factors in modulating liver glucokinase expression.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
15Silver nanoparticles (AgNPs) have found a variety of uses including biomedical materials; however, studies of the cytotoxicity of AgNPs by size effects are only in the beginning stage. In this study, we examined the size-dependent cellular toxicity of AgNPs using three different characteristic sizes (∼ 10, 50, and 100 nm) against several cell lines including MC3T3-E1 and PC12. The cytotoxic effect determined based on the cell viability, intracellular reactive oxygen species generation, lactate d
LARC patients achieving ypT0N0 after preoperative CRT had favorable long-term outcomes, whereas positive ypN status had a poor prognosis even after total regression of primary tumor.
MLD is a useful indicator of risk for development of severe RP after 3D conformal radiation therapy in patients with lung cancer.
3D-CRT was associated with a 54.3% objective response rate for primary tumors and a 39.0% objective response rate for PVT. Both primary tumor and PVT responses were found to be prognostic factors for overall survival. The present results suggest 3D-CRT is a practical treatment option in HCC patients for whom TACE is ineffective or unsuitable.
Liver glucokinase (LGK) plays an essential role in controlling blood glucose levels and maintaining cellular metabolic functions. Expression of LGK is induced mainly regulated by insulin through sterol regulatory element-binding protein-1c (SREBP-1c) as a mediator. Since LGK expression is known to be decreased in the liver of liver X receptor (LXR) knockout mice, we have investigated whether LGK might be directly activated by LXRalpha. Furthermore, we have studied interrelationship between trans
Research Areas
Dive deeper into Tae Hyun Kim's research on Nubint
Open this lab's papers in the app to read with AI, summarize, and cite in your writing.